IPPRA / Grant Monitor

2026-07-07
← Board

NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)

RFA-RM-27-002 · National Institutes of Health

biomedical clinical ai data science materials manufacturing Health

Closes
2026-08-17 · 41 d
Award ceiling
$475,000
Award floor
$475,000
Program funding
$23,000,000
Expected awards
30
Cost sharing
No
Posted
2026-06-26
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Supports early-stage investigators at eligible U.S. institutions to pursue exceptionally creative, high-risk, high-reward biomedical research projects in any area of the NIH mission, including basic, translational, or clinical work.

Funds
basic research
University
direct
social behavioral
minor
physical sciences
minor
engineering
substantial
life biomedical
central
computational data
substantial

⚑ Early-stage investigators only; see NOFO eligibility details. · Foreign organizations and non-domestic components of U.S. organizations are not eligible; foreign components are allowed. · High-risk/high-reward program; applications should be exceptionally innovative.

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: substantial; funds basic research
IPPRA 48 partial outside portfolio topics; social/behavioral work is minor; funds basic research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Tom Love Innovation Hub 30 weak prototyping/demonstration stage; deep-tech content

Description

The NIH Director"s New Innovator Award supports early-stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome; topics may involve basic, translational, or clinical research. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Director"s New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) program of the NIH Common Fund.

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <NewInnovatorAwards@mail.nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING